In the Spotlight
Awards and Honors
2016 AAAS Fellow
Larry became an elected fellow of the American Association for the Advancement of Sciences (AAAS) for his discoveries about the molecular basis for lymphocyte homing to the brain in relapsing multiple sclerosis, which led to an effective approved therapy for MS.
2016 Cerami Award
2015 National Academy of Sciences
2011 Charcot Award
2009 NAS Institute of Medicine
2008 Endowed Professorship
2004 John Dystel Prize
1994 Dr. Freidrich-Sasse Award
From the Free University of Berlin, this prize was awarded to Larry for outstanding contributions in immunology.
1979 S. Weir Mitchell Award
Sponsored by the American Brain Foundation and endowed by the Alliance Founders and S. Weir Mitchell Permanent Endowment, this American Academy of Neurology award is designed to encourage basic research in neuroscience by physicians in clinical neurology training programs.
Cheers to 30 Years!
Congratulations to Larry and retired lab manager Mae Lim for celebrating 30 successful years of hard work together at Stanford (1980-2010).
The real deal!
Larry's first official MLB foul ball at AT&T Park.
In the News
WebMD: Path to a Breakthrough
This new video web series, hosted by Good Morning America's Robin Roberts, sheds light on how medical innovations, including precision medicine, immunotherapy, and biologics, are providing doctors with powerful new tools to treat disease. Christopher Lock, clinical associate professor of neurology, and Lawrence Steinman, the George A. Zimmermann Professor, professor of pediatrics, and professor of neurology, are featured in a segment on treating multiple sclerosis patients with biologics – complex drugs made in living cells that are chemically and genetically engineered.
Lucky Larry: Reflections on a career in immunology and neurology. By Becky Bach on June 22, 2016.
Lawrence Steinman, MD, the George A. Zimmerman Professor and a professor of pediatrics at Stanford, is a visionary in the field of neurology. This is the story of Dr. Steinman’s scientific journey.
Researchers link Pandemrix flu vaccinations to narcolepsy
An international team of researchers has found evidence that the GlaxoSmithKline Pandemrix flu vaccination – which was widely distributed during the 2009 swine flu pandemic – may have caused rare cases of narcolepsy. Steinman described this finding as a “first step” in their pursuit to nail down the cause of narcolepsy.
Immune response to a flu protein yields new insights into narcolepsy
A swine flu vaccine may have caused rare cases of narcolepsy by stimulating antibodies to attack brain cells that help regulate sleep.
Does Amyloid Kill in Alzheimer's, Heal in MS?
Two groups have recently made strides with amyloid beta, the supposed main villain in Alzheimer’s disease. But while one group is tackling Alzheimer’s by reducing amyloid beta, the other is tackling multiple sclerosis (MS) by using amyloid beta. “It’s all fascinating,” Stanford University neurologist Lawrence Steinman told Bioscience Technology.
DNA 'reverse' vaccine reduces levels of immune cells believed responsible for type-1 diabetes, study shows
Accused of complicity in Alzheimer's, amyloid proteins may be getting a bad rap, study finds
A pair of recent research studies from the Stanford University School of Medicine sets a solid course toward rehabilitating the reputation of the proteins that form amyloid tangles, or plaques. In the process, they appear poised to turn the field of neurobiology on its head.
Researchers discover reviled substance involved in Alzheimer's can reverse paralysis in mice with multiple sclerosis
Cystamine as a potential treatment for Huntington's Disease
Earlier research has also shown that cystamine inactivates transglutaminase (TGase), an enzyme that helps produce these clumps of huntingtin protein. Therefore, Steinman and his former graduate student reasoned that cystamine might control the disease by preventing the formation of huntingtin protein clumps.